Nonsymmetric P2/P2' cyclic urea HIV protease inhibitors. Structure-activity relationship, bioavailability, and resistance profile of monoindazole-substituted P2 analogues

Journal of Medicinal Chemistry
G V De LuccaG L Trainor

Abstract

Using the structural information gathered from the X-ray structures of various cyclic urea/HIVPR complexes, we designed and synthesized many nonsymmetrical P2/P2'-substituted cyclic urea analogues. Our efforts concentrated on using an indazole as one of the P2 substituents since this group imparted enzyme (Ki) potency as well as translation into excellent antiviral (IC90) potency. The second P2 substituent was used to adjust the physical and chemical properties in order to maximize oral bioavailability. Using this approach several very potent (IC90 11 nM) and orally bioavailable (F% 93-100%) compounds were discovered (21, 22). However, the resistance profiles of these compounds were inadequate, especially against the double (I84V/V82F) and ritonavir-selected mutant viruses. Further modification of the second P2 substituent in order to increase H-bonding interactions with the backbone atoms of residues Asp 29, Asp 30, and Gly 48 led to analogues with much better resistance profiles. However, these larger analogues were incompatible with the apparent molecular weight requirements for good oral bioavailability of the cyclic urea class of HIVPR inhibitors (MW < 610).

References

Mar 28, 1995·Proceedings of the National Academy of Sciences of the United States of America·D J KempfX P Kong
Apr 15, 1995·Lancet·G C YeeD T Lowenthal
Dec 30, 1994·Biochemical and Biophysical Research Communications·D L WinslowL T Bacheler
Apr 26, 1994·Proceedings of the National Academy of Sciences of the United States of America·J P VaccaE Roth
Dec 15, 1995·The Journal of Biological Chemistry·T Ridky, J Leis
Oct 1, 1995·Antimicrobial Agents and Chemotherapy·M BryantK Houseman
Jan 26, 1996·The Journal of Organic Chemistry·Michael E. PierceGeorge C. Emmett

❮ Previous
Next ❯

Citations

Feb 19, 2000·Biochemical and Biophysical Research Communications·B KotamarthiS Miertus
Mar 28, 2008·Journal of Computer-aided Molecular Design·Rajni Garg, Barun Bhhatarai
Sep 17, 2009·Biological Trace Element Research·Fikret KaratasHaki Kara
Oct 1, 1998·Antiviral Research·A MollaD J Kempf
Nov 27, 1999·Bioorganic & Medicinal Chemistry Letters·M PatelS S Ko
Jul 15, 2011·Acta Crystallographica. Section E, Structure Reports Online·R J ButcherH S Yathirajan
Jul 15, 2011·Acta Crystallographica. Section E, Structure Reports Online·Ore KuyinuRay J Butcher
Nov 6, 2012·Acta Crystallographica. Section E, Structure Reports Online·S Rizwana BegumA G Anitha
Nov 21, 2007·Organic & Biomolecular Chemistry·Giovanni PiersantiPaolo Carminati
Sep 25, 2019·Organic & Biomolecular Chemistry·Yan-Ling LiuJian-Zhong Chen
Aug 7, 2014·Molecular Diversity·Mir Rasul MousaviSayyed Mostafa Habibi-Khorassani
Mar 2, 2021·Medicinal Research Reviews·Yohan MalkiNicolas Masurier
Mar 3, 2009·Journal of Medicinal Chemistry·Luciana GavernetLuis E Bruno-Blanch
Nov 14, 2000·The Journal of Organic Chemistry·K T Sprott, P R Hanson
May 24, 2000·Organic Letters·P W Baures

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.